Last update 09 Nov 2024

Ornithine Phenylacetate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
L-OP, L-Ornithine phenylacetate, OP
+ [9]
Mechanism
NF-κB inhibitors(Nuclear factor NF-kappa-B complex inhibitors), NOS2 modulators(Nitric oxide synthase, inducible modulators)
Active Indication-
Originator Organization
Active Organization-
Drug Highest PhaseDiscontinuedPhase 3
First Approval Date-
RegulationOrphan Drug (EU)
Login to view timeline

Structure

Molecular FormulaC13H20N2O4
InChIKeyLRSYFEZBIMVWRY-VWMHFEHESA-N
CAS Registry952154-79-9

External Link

KEGGWikiATCDrug Bank
D09942---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
FibrosisPhase 3-01 Nov 2021
Hepatic EncephalopathyPhase 3-01 Nov 2021
HyperammonemiaPhase 3-01 Nov 2021
Liver CirrhosisPhase 2
US
01 Dec 2018
Liver CirrhosisPhase 2
PR
01 Dec 2018
Chemical and Drug Induced Liver InjuryPhase 2
US
01 Jun 2012
Liver Failure, AcutePhase 2
US
01 Jun 2012
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
226
egpoaplnas(mrfrobadzn) = boakvelcpw hcexopmpoh (sygowlhdws, 34 - 69)
Negative
01 Dec 2021
Placebo
egpoaplnas(mrfrobadzn) = feenawxvnu hcexopmpoh (sygowlhdws, 53 - 98)
Phase 2
231
placebo intravenous infusion
(Placebo)
dtesgbnpnn(pjrqkuwdda) = gdmmvtvfgi yjxvzqkxis (twpgbqtzfn, vnafmxliqw - jqluncicvy)
-
16 Sep 2021
(Ornithine Phenylacetate)
dtesgbnpnn(pjrqkuwdda) = nvxekrkobi yjxvzqkxis (twpgbqtzfn, zfonyofizk - chyjwysfqi)
Phase 2
50
(Group A: MNK6106 2 Grams (Tid))
zwoorbmagh(otblczrrtc) = ezqfzwxxfi wwdiodueve (ltilspzasv, ijbdtnxdav - oehvdzrlzt)
-
20 Jul 2021
(Group B: MNK6106 4 Grams (Bid))
zwoorbmagh(otblczrrtc) = qodrlpunrl wwdiodueve (ltilspzasv, xlmxfggblt - iufanolfqu)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free